BENIGN ENLARGEMENT OF THE SUBARACHNOID SPACES

This adverse event was reported 27 times

These drugs are most commonly taken by patients reporting BENIGN ENLARGEMENT OF THE SUBARACHNOID SPACES:

# Drug Count
0 QUETIAPINE 8
1 ASPIRIN 2
2 ASPIRIN 325 MG 2
3 ASPIRIN 81 MG 2
4 CANAKINUMAB 2
5 CEFOTAXIME 2
6 CEFOTAXIME INJECTION 2
7 FOLIC ACID 2
8 LEVETIRACETAM 2
9 LEVETIRACETAM IN SODIUM CHLORIDE 2
See all common drugs associated with BENIGN ENLARGEMENT OF THE SUBARACHNOID SPACES

BENIGN ENLARGEMENT OF THE SUBARACHNOID SPACES is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CEFOTAXIME INJECTION 2 0.0005
1 GLYCERIN SUPPOSITORY 1 0.0004
2 GLYCERIN SUPPOSITORIES 1 0.0004
3 GALSULFASE 1 0.0003
4 CANAKINUMAB 2 0.0002
5 PHYTONADIONE 1 0.0001
6 SIPONIMOD 1 0.0001
7 CAPTOPRIL 1 0.0001
8 NIACIN 1 0.0001
9 ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR 1 0.0001
See all drugs enriched for association with BENIGN ENLARGEMENT OF THE SUBARACHNOID SPACES